First National Bank Of Mount Dora Trust Investment Services Has Lifted By $412,930 Its Pfizer (PFE) Holding; Gsa Capital Partners Llp Lifted By $2.61 Million Its Matson (MATX) Holding

First National Bank Of Mount Dora Trust Investment Services increased Pfizer Inc (PFE) stake by 9.43% reported in 2017Q3 SEC filing. First National Bank Of Mount Dora Trust Investment Services acquired 11,798 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The First National Bank Of Mount Dora Trust Investment Services holds 136,863 shares with $4.89 million value, up from 125,065 last quarter. Pfizer Inc now has $208.27B valuation. The stock increased 0.81% or $0.28 during the last trading session, reaching $34.94. About 20.45M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 14, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Gsa Capital Partners Llp increased Matson Inc (MATX) stake by 201.11% reported in 2017Q3 SEC filing. Gsa Capital Partners Llp acquired 93,158 shares as Matson Inc (MATX)’s stock declined 18.22%. The Gsa Capital Partners Llp holds 139,479 shares with $3.93M value, up from 46,321 last quarter. Matson Inc now has $1.48 billion valuation. The stock increased 0.75% or $0.26 during the last trading session, reaching $34.87. About 180,993 shares traded. Matson, Inc. (NYSE:MATX) has declined 5.12% since February 14, 2017 and is downtrending. It has underperformed by 21.82% the S&P500.

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.85’s average target is 14.05% above currents $34.94 stock price. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. As per Wednesday, January 31, the company rating was maintained by Leerink Swann. Piper Jaffray maintained the stock with “Overweight” rating in Friday, August 28 report. The firm has “Hold” rating by Jefferies given on Wednesday, August 16. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Monday, June 20. Argus Research maintained the shares of PFE in report on Wednesday, July 29 with “Buy” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by Jefferies on Thursday, October 26. The firm earned “Equal-Weight” rating on Tuesday, December 1 by Barclays Capital. As per Friday, March 24, the company rating was maintained by Societe Generale. Goldman Sachs maintained Pfizer Inc. (NYSE:PFE) rating on Monday, April 18. Goldman Sachs has “Neutral” rating and $35 target. The company was maintained on Friday, August 14 by Piper Jaffray.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. First City Cap Mgmt holds 90,873 shares. Viking Fund Mngmt Ltd Liability Co has invested 0.82% of its portfolio in Pfizer Inc. (NYSE:PFE). 34.44M were accumulated by Lsv Asset Management. King Wealth Mgmt Limited Com reported 13,509 shares. Sentry reported 2.79M shares stake. 6,788 were accumulated by Long Road Invest Counsel Limited. Tradewinds Mngmt Lc holds 0.15% or 8,180 shares. Interocean Ltd Liability Co holds 0.04% or 7,673 shares. Thomaspartners invested in 2.1% or 7.34M shares. Signature Estate Advisors holds 5,825 shares or 0.02% of its portfolio. Essex Mngmt Ltd Limited Liability Company accumulated 19,213 shares or 0.09% of the stock. Dorsey & Whitney Tru holds 1.26% of its portfolio in Pfizer Inc. (NYSE:PFE) for 177,306 shares. Northeast Fincl Consultants has invested 17.17% of its portfolio in Pfizer Inc. (NYSE:PFE). Lpl Financial Ltd Com accumulated 1.42 million shares or 0.18% of the stock. Moreover, Sunbelt Secs Inc has 0.36% invested in Pfizer Inc. (NYSE:PFE) for 9,670 shares.

Since August 21, 2017, it had 0 buys, and 8 selling transactions for $12.56 million activity. MACKENZIE ALEXANDER R sold $249,750 worth of stock. Shares for $263,693 were sold by OLSON LAURIE J. Another trade for 197,168 shares valued at $6.70M was sold by READ IAN C. 38,230 shares were sold by SUSMAN SALLY, worth $1.34M. Shares for $296,560 were sold by JOHNSON RADY A. $3.21 million worth of Pfizer Inc. (NYSE:PFE) was sold by DAMELIO FRANK A on Thursday, August 31.

Among 6 analysts covering Matson (NYSE:MATX), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Matson has $52 highest and $23.0 lowest target. $44.50’s average target is 27.62% above currents $34.87 stock price. Matson had 15 analyst reports since August 5, 2015 according to SRatingsIntel. Stifel Nicolaus downgraded Matson, Inc. (NYSE:MATX) rating on Tuesday, November 8. Stifel Nicolaus has “Hold” rating and $38 target. The rating was downgraded by Wells Fargo to “Underperform” on Friday, August 18. The stock of Matson, Inc. (NYSE:MATX) has “Hold” rating given on Monday, January 29 by Wells Fargo. The rating was upgraded by Stifel Nicolaus to “Buy” on Friday, August 18. The stock has “Buy” rating by Stifel Nicolaus on Sunday, January 28. On Wednesday, August 5 the stock rating was maintained by Stifel Nicolaus with “Buy”. Stephens downgraded the stock to “Hold” rating in Friday, August 18 report. Stifel Nicolaus maintained Matson, Inc. (NYSE:MATX) on Thursday, September 21 with “Buy” rating. The stock of Matson, Inc. (NYSE:MATX) has “Mkt Perform” rating given on Monday, November 9 by FBR Capital. The firm earned “Neutral” rating on Thursday, December 15 by Seaport Global.

Gsa Capital Partners Llp decreased Time Inc New (NYSE:TIME) stake by 108,670 shares to 39,053 valued at $527,000 in 2017Q3. It also reduced Costco Whsl Corp New (NASDAQ:COST) stake by 29,945 shares and now owns 1,315 shares. Icon Plc (NASDAQ:ICLR) was reduced too.

Since August 28, 2017, it had 1 buy, and 0 insider sales for $24,135 activity. LAU CONSTANCE H also bought $24,135 worth of Matson, Inc. (NYSE:MATX) shares.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: